Royalty Pharma plc
Balance Sheet
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $1.76B | $843.0M | $477.0M | $936.4M | $2.17B | $1.98B | $1.71B | $991.6M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $2.58B | $1.56B | $1.27B | $1.73B | $2.95B | $2.63B | $2.55B | $2.34B |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | $0 | $0 |
| Total Assets | $17.66B | $16.13B | $16.38B | $15.86B | $17.12B | $17.07B | $16.81B | $17.67B |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | — | — | — |
| Total Current Liabilities | $275.7M | $124.6M | $161.4M | $127.9M | $1.17B | $1.12B | $1.17B | $1.13B |
| Long-Term Debt | $7.60B | $6.14B | $6.14B | $6.13B | $6.13B | $6.12B | $6.12B | $6.11B |
| Total Liabilities | $7.90B | $6.27B | $6.30B | $6.27B | $7.31B | $7.25B | $7.29B | $7.26B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $2.38B | $2.43B | $2.52B | $2.13B | $2.25B | $2.22B | $1.96B | $2.50B |
| Total Stockholders' Equity | $9.75B | $9.86B | $10.08B | $9.59B | $9.81B | $9.82B | $9.53B | $10.42B |